The founding and management team of Valerius

Valerius is led by a team with proven track-records in biopharmaceutical development and finance

Dr. Andreas Herrmann

Founder and CEO

Dr. Andreas Herrmann has 25 years of experience in biopharmaceutical and biosimilar development.

From 2013-2016, Dr. Herrmann built up Alvotech, a leading biosimilars company based in Iceland with a four product pipeline and 14,000 sqm manufacturing plant and made two successful acquisitions and other strategic initiatives.

Between 2003-2013, Dr. Herrmann (co-)founded seven different biotech companies including Celonic (CMO), Baliopharm (innovator company for autoimmune diseases, oncology), Synimmune (bispecific antibodies, oncology), ICAAN (Aesthetic Navigation), Icelandic Natura (Topica), and Probiocon (Consulting).

In 1996, Dr. Herrmann co-founded Cardion AG where he was heading the R&D department
until 2003.

He received his PhD in biochemistry in the field of neurobiology at the University of Cologne and worked as an associate professor in the department of cardiovascular physiology at the University of Düsseldorf (1995-1997).

Thomas Fleig

Chief Financial Officer

Thomas Fleig has gained more than eleven years of experience in the finance industry and as an entrepreneur.

Following his M.Sc. degree at the University of Exeter, Mr. Fleig was responsible to introduce a London based wealth management firm in the DACH region.

Since 2008, Mr. Fleig worked as a manager in Transaction Advisory Services at Ernst&Young and as a contractor for Private Equity and Corporate clients in various sectors. In addition, he set-up an interior design trading company and was appointed as a Director of various holding companies for a leading US private equity investor.


Stefanie Herrmann-Zahn

Chief Operating Officer

Stefanie Herrmann-Zahn has about 20 years of experience in the development of biopharmaceutical compounds.

Mrs. Herrmann-Zahn gained her diploma as a chemical engineer at Krefeld in 1997. She then joined AGS, where she worked as scientist in the fields of fermentation and enzyme purification. In 1998, she joined Cardion, where she led the biopharmaceutical development department including cell culture, process development, manufacturing and quality control.

In 2003, Mrs. Herrmann-Zahn worked at Celonic GmbH as Head of Process Development in Jülich before she became Head of Production at the GMP Facility of Celonic AG in Basel. Furthermore, she was appointed as VP Project Management.

From 2014–2016, Mrs. Herrmann-Zahn was VP Project Management at Alvotech, where she was leading cross-functional teams for the development of four biosimilar products.

We use cookies to improve your user experience. By continuing to browse the site you are giving your consent for us to set cookies. If you don't agree, you can find here further informations.

OK, I agree.